- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 17, 2025 | 37.98M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $94.92M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $241.02M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $153.42M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $146.68M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $188.13M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $176.54M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $251.84M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $381.91M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.11B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.03B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 37.69M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $16.54M |
| Capex | Q1 2025 · Mar 31, 2024 | $3.53M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $34.06M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $682.97M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $667.48M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.48 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.49 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $25.91M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $16.01M |
| Net Income | Q1 2025 · Mar 31, 2024 | $18M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $15.4M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $98.09M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $51.49M |
| Revenue | Q1 2025 · Mar 31, 2024 | $149.58M |